References
- Abbasi H., Kouchak M., Mirveis Z., Hajipour F., Khodarahmi M., Rahbar N., Handali S. (2023). What we need to know about liposomes as drug nanocarriers: an updated review. Adv. Pharm. Bull., 13: 7–23.
- Agarwal K. (2022). Liposome assisted drug delivery –an updated review. Indian J. Pharm. Sci., 84.
- Ahmadi Ashtiani H.R., Bishe P., Lashgari N.-A., Nilforoushzadeh M.A., Zare S. (2016). Liposomes in cosmetics. J. Skin Stem Cell., 3.
- Algburi A., Comito N., Kashtanov D., Dicks L.M.T., Chikindas M.L. (2017). Control of biofilm formation: antibiotics and beyond. Appl. Environ. Microbiol., 83.
- Alghuthaymi M.A., Hassan A.A., Kalia A., Ahl R.M.H.S. El, Hamaky A.A.M. El, Oleksak P., Kuca K., Abd-Elsalam K.A. (2021). Antifungal nano-therapy in veterinary medicine: current status and future prospects. J. Fungi., 7: 494.
- Andra V.V.S.N.L., Pammi S.V.N., Bhatraju L.V.K.P., Ruddaraju L.K. (2022). A comprehensive review on novel liposomal methodologies, commercial formulations, clinical trials and patents. BioN-anoScience, 12: 274–291.
- André A.S., Dias J.N.R., Aguiar S.I., Leonardo A., Nogueira S., Amaral J.D., Fernandes C., Gano L., Correia J.D.G., Cavaco M., Neves V., Correia J., Castanho M., Rodrigues C.M.P., Gaspar M.M., Tavares L., Aires-da-Silva F. (2023). Panobinostat-loaded folate targeted liposomes as a promising drug delivery system for treatment of canine B-cell lymphoma. Front. Vet. Sci., 10.
- Anon (2019). Animal medicine global market report 2019. The Market Research Company. https://www.prnewswire.com/news-releases/animal-medicine-global-market-report-2019-300839972.html [accessed March 29, 2024].
- Bai D.-P., Lin X.-Y., Huang Y.-F., Zhang X.-F. (2018). Theranostics aspects of various nanoparticles in veterinary medicine. Intl. J. Mol. Sci., 19: 3299.
- Baig N., Kammakakam I., Falath W. (2021). Nanomaterials: a review of synthesis methods, properties, recent progress, and challenges. Mat. Adv., 2: 1821–1871.
- Bailey R. (2022). Nocita®. https://www.mynavas.org/post/nocita [accessed December 25, 2023].
- Barenholz Y. (2012). Doxil® –The first FDA-approved nano-drug: lessons learned. J. Control. Release., 160: 117–134.
- Becker W.M., Mama K.R., Rao S., Palmer R.H., Egger E.L. (2013). Prevalence of dysphoria after fentanyl in dogs undergoing stifle surgery. Vet. Surg., 42: 302–307.
- Belshaw Z., Asher L., Dean R.S. (2016). The attitudes of owners and veterinary professionals in the United Kingdom to the risk of adverse events associated with using non-steroidal anti-inflammatory drugs (NSAIDs) to treat dogs with osteoarthritis. Prev. Vet. Med., 131: 121–126.
- Bidart J., Kornuta C., Gammella M., Gnazzo V., Soria I., Langellotti C., Mongini C., Galarza R., Calvinho L., Lupi G., Quattrocchi V., Marcipar I., Zamorano P. (2020). A new cage-like particle adjuvant enhances protection of foot-and-mouth disease vaccine. Front. Vet. Sci., 7.
- Biller B., Berg J., Garrett L., Ruslander D., Wearing R., Abbott B., Patel M., Smith D., Bryan C. (2016). 2016 AAHA Oncology Guidelines for Dogs and Cats. J. Am. Anim. Hospital Assoc., 52: 181–204.
- Boston S., Henderson R.A. (2014). Role of surgery in multimodal cancer therapy for small animals. Vet. Clin. North Am. Small Animal Prac., 44: 855–870.
- Bozzuto G., Molinari A. (2015). Liposomes as nanomedical devices. Intl. J. Nanomed., 10: 975–999.
- Bredlau A.L., Motamarry A., Chen C., McCrackin M.A., Helke K., Armeson K.E., Bynum K., Broome A.-M., Haemmerich D. (2018). Localized delivery of therapeutic doxorubicin dose across the canine blood–brain barrier with hyperthermia and temperature sensitive liposomes. Drug Deliv., 25: 973–984.
- Bulbake U., Doppalapudi S., Kommineni N., Khan W. (2017). Liposomal formulations in clinical use: an updated review. Pharmaceutics, 9: 12.
- Carrique-Mas J., Van Cuong N., Truong B.D., Phu D.H., Phuc T.M., Turner H., Thwaites G., Baker S. (2019). Affordability of antimicrobials for animals and humans in Vietnam: a call to revise pricing policies. Intl. J. Antimicrob. Agents., 54: 269–270.
- Carvalho S.G., Araujo V.H.S., dos Santos A.M., Duarte J.L., Silvestre A.L.P., Fonseca-Santos B., Villanova J.C.O., Gremião M.P.D., Chorilli M. (2020). Advances and challenges in nanocarriers and nanomedicines for veterinary application. Intl. J. Pharm., 580.
- Castelli D.D., Boffa C., Giustetto P., Terreno E., Aime S. (2014). Design and testing of paramagnetic liposome-based CEST agents for MRI visualization of payload release on pH-induced and ultra-sound stimulation. J. Biol. Inorg. Chem., 19: 207–214.
- Chariou P.L., Ortega-Rivera O.A., Steinmetz N.F. (2020). Nanocarriers for the delivery of medical, veterinary, and agricultural active ingredients. ACS Nano., 14: 2678–2701.
- Chehelgerdi M., Chehelgerdi M., Allela O.Q.B., Pecho R.D.C., Jayasankar N., Rao D.P., Thamaraikani T., Vasanthan M., Viktor P., Lakshmaiya N., Saadh M.J., Amajd A., Abo-Zaid M.A., Castillo-Acobo R.Y., Ismail A.H., Amin A.H., Akhavan-Sigari R. (2023). Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol. Cancer., 22: 169.
- Cheng X., Yan H., Pang S., Ya M., Qiu F., Qin P., Zeng C., Lu Y. (2022). Liposomes as multifunctional nano-carriers for medicinal natural products. Front. Chem., 10.
- Cohen N.D., Giguère S., Burton A.J., Rocha J.N., Berghaus L.J., Brake C.N., Bordin A.I., Coleman M.C. (2016). Use of liposomal gentamicin for treatment of 5 foals with experimentally induced Rhodococcus equi pneumonia. J. Vet. Intern. Med., 30: 322.
- da Silva C.F., Almeida T., de Melo Barbosa R., Cardoso J.C., Morsink M., Souto E.B., Severino P. (2020). New trends in drug delivery systems for veterinary applications. Pharm. Nanotechnol., 9: 15–25.
- DeFrancesco L. (2020). Whither COVID-19 vaccines? Nat. Biotechnol., 38: 1132–1145.
- Degobert G., Aydin D., Mosqueira F., Araújo R.S. (2021). Lyophilization of nanocapsules: instability sources, formulation and process parameters. Pharmaceutics, 13: 1112.
- Deshpande P.P., Biswas S., Torchilin V.P. (2013). Current trends in the use of liposomes for tumor targeting. Nanomedicine (London, England), 8: 1509–1528.
- De Sousa Lobato K.B., Paese K., Forgearini J.C., Guterres S.S., Jablonski A., De Oliveira Rios A. (2013). Characterisation and stability evaluation of bixin nanocapsules. Food Chem., 141: 3906–3912.
- Dessale M., Mengistu G., Mengist H.M. (2022). Nanotechnology: a promising approach for cancer diagnosis, therapeutics and theragnosis. Intl. J. Nanomed., 17: 3735–3749.
- Dhakal S., Cheng X., Salcido J., Renu S., Bondra K., Lakshmanappa Y.S., Misch C., Ghimire S., Feliciano-Ruiz N., Hogshead B., Krakowka S., Carson K., McDonough J., Lee C.W., Renukaradhya G.J. (2018). Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs. Intl. J. Nanomed., 13: 6699–6715.
- Dos Anjos D.S., Bueno C., Magalhães L.F., Magalhães G.M., Mattos-Junior E., Pinto M.M.R., De Nardi A.B., Brunner C.H.M., Leis-Filho A.F., Calazans S.G., Fonseca-Alves C.E. (2019). Electrochemotherapy induces tumor regression and decreases the proliferative index in canine cutaneous squamous cell carcinoma. Sci. Rep., 9: 15819.
- Eleraky N.E., Allam A., Hassan S.B., Omar M.M. (2020). Nanomedicine fight against antibacterial resistance: an overview of the recent pharmaceutical innovations. Pharmaceutics, 12: 142.
- El-Sayed A., Kamel M. (2020). Advanced applications of nanotechnology in veterinary medicine. Environ. Sci. Pollut. Res., 27: 19073–19086.
- Epstein M.E., Rodan I., Griffenhagen G., Kadrlik J., Petty M.C., Robertson S.A., Simpson W. (2015). 2015 AAHA/AAFP Pain Management Guidelines for Dogs and Cats. J. Feline Med. Surg., 17: 251–272.
- Faria Lainetti P. de, Zuliani F., Leis-Filho A.F., Fonseca Alves R.H., Fonseca-Alves C.E. (2020). Controlled drug delivery vehicles in veterinary oncology: state-of-the-art and future directions. Processes, 8.
- Farjadian F., Ghasemi A., Gohari O., Roointan A., Karimi M., Hamblin M.R. (2019). Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities. Nanomedicine, 14: 93–126.
- Fathi S., Oyelere A.K. (2016). Liposomal drug delivery systems for targeted cancer therapy: is active targeting the best choice? Future Med. Chem., 8: 2091–2112.
- FDA (2016). NADA 141-461 Nocita® dog. Freedom of information summary: original new animal drug application. US FDA. https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/3952 [accessed December 25, 2023].
- FDA (2018). NADA 141-461. Nocita cat®. Freedom of information summary: original new animal drug application. US FDA. https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/3952 [accessed December 25, 2023].
- Ferreira M., Ogren M., Dias J.N.R., Silva M., Gil S., Tavares L., Aires-da-Silva F., Gaspar M.M., Aguiar S.I. (2021). Liposomes as antibiotic delivery systems: a promising nanotechnological strategy against antimicrobial resistance. Molecules, 26: 2047.
- Filipczak N., Pan J., Yalamarty S.S.K., Torchilin V.P. (2020). Recent advancements in liposome technology. Adv. Drug Deliv. Rev., 156: 4–22.
- Frolov V.A., Shnyrova A.V., Zimmerberg J. (2011). Lipid polymorphisms and membrane shape. Cold Spring Harb. Perspect. Biol., 3: a004747.
- Gao J., Ochyl L.J., Yang E., Moon J.J. (2017). Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens. Intl. J. Nanomed., 12: 1251–1264.
- Gatto M.S., Johnson M.P., Najahi-Missaoui W. (2024). Targeted liposomal drug delivery: overview of the current applications and challenges. Life, 14: 672.
- Ghosh R., De M. (2023). Liposome-based antibacterial delivery: an emergent approach to combat bacterial infections. ACS Omega, 8: 35442–35451.
- Giddam A.K., Zaman M., Skwarczynski M., Toth I. (2012). Liposome-based delivery system for vaccine candidates: constructing an effective formulation. Nanomedicine, 7: 1877–1893.
- Gonzalez Gomez A., Hosseinidoust Z. (2020). Liposomes for antibiotic encapsulation and delivery. ACS Infect. Dis., 6: 896–908.
- Gordon-Evans W.J., Suh H.Y., Guedes A.G. (2019). Controlled, non-inferiority trial of bupivacaine liposome injectable suspension. J. Feline Med. Surg., 22: 916–921.
- Grubb T., Lobprise H. (2020). Local and regional anaesthesia in dogs and cats: descriptions of specific local and regional techniques (Part 2). Vet. Med. Sci., 6: 218–234.
- Guimarães D., Cavaco-Paulo A., Nogueira E. (2021). Design of liposomes as drug delivery system for therapeutic applications. Intl. J. Pharm., 601.
- Gyanani V., Haley J.C., Goswami R. (2021). Challenges of current anticancer treatment approaches with focus on liposomal drug delivery systems. Pharmaceuticals, 14.
- Handali S., Moghimipour E., Rezaei M., Ramezani Z., Kouchak M., Amini M., Angali K.A., Saremy S., Dorkoosh F.A. (2018). A novel 5-Fluorouracil targeted delivery to colon cancer using folic acid conjugated liposomes. Biomed. Pharmacother., 108: 1259–1273.
- Hassan A.A., El Hamaky A.M., Sayed El Ahl R.M., Oraby N.H., Man-sour M.K. (2020). Nanomaterials and nanocomposite applications in veterinary medicine. Multifunctional Hybrid Nanomater. Sustainable Agri-food Ecosystems, pp. 583–638.
- Hatakeyama H., Akita H., Harashima H. (2013). The polyethyleneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumors. Biol. Pharm. Bull., 36: 892–899.
- Hill E.K., Li J. (2017). Current and future prospects for nanotechnology in animal production. J. Animal Sci. Biotechnol., 8: 26.
- Hu R., Liu H., Wang M., Li J., Lin H., Liang M., Gao Y., Yang M. (2020). An OMV-based nanovaccine confers safety and protection against pathogenic Escherichia coli via both humoral and predominantly Th1 immune responses in poultry. Nanomaterials, 10: 2293.
- Hu Y.-J., Ju R.-J., Zeng F., Qi X.-R., Lu W.-L. (2021). Liposomes in drug delivery: status and advances, In: Liposome-Based Drug Delivery Systems. Biomaterial Engineering, Lu W.L., Qi X.R. (eds). Springer, Berlin, Heidelberg, pp. 3–24.
- Hua S., Wu S.Y. (2013). The use of lipid-based nanocarriers for targeted pain therapies. Front. Pharmacol., 4.
- Hussain S. (2019). Immunization and vaccination, In: Psychiatry of Pandemics, Cham: Springer International Publishing, pp. 153–177.
- Islam Shishir M.R., Karim N., Gowd V., Zheng X., Chen W. (2019). Liposomal delivery of natural product: a promising approach in health research. Trends Food Sci. Tech., 85: 177–200.
- Jaafer N.S., Balqees H.A., Al-Bayati M.A. (2021). Comparison between Newcastle disease vaccine and liposomal entrapped Newcastle disease vaccine in chicks. J. Genet. Environ. Resour. Conserv., 9: 157–167.
- Johnson R.J., Kerr C.L., Enouri S.S., Modi P., Lascelles B.D.X., del Castillo J.R.E. (2017). Pharmacokinetics of liposomal encapsulated buprenorphine suspension following subcutaneous administration to cats. J. Vet. Pharmacol. Ther., 40: 256–269.
- Kang M.H., Yoon H.Y., Choi Y.W. (2017). RIPL peptide as a novel cell-penetrating and homing peptide: design, characterization, and application to liposomal nanocarriers for hepsin-specific intracellular drug delivery. Nanostruct. Cancer Ther., 129–157.
- Karunakaran B., Gupta R., Patel P., Salave S., Sharma A., Desai D., Benival D., Kommineni N. (2023). Emerging trends in lipid-based vaccine delivery: a special focus on developmental strategies, fabrication methods, and applications. Vaccines, 11.
- Kent M.S. (2013). Cats and chemotherapy: Treat as “small dogs” at your peril. J. Feline Med. Surg., 15: 419–424.
- Knight-Jones T.J.D., Edmond K., Gubbins S., Paton D.J. (2014). Veterinary and human vaccine evaluation methods. Proc. Royal Society B Biol. Sci., 281: 20132839.
- Kumari P., Ghosh B., Biswas S. (2016). Nanocarriers for cancer-targeted drug delivery. J. Drug Target., 24: 179–191.
- Kumosani T., Yaghmoor S., Abdulaal W.H., Barbour E. (2020). Evaluation in broilers of aerosolized nanoparticles vaccine encapsulating immuno-stimulant and antigens of avian influenza virus/Mycoplasma gallisepticum. BMC Vet. Res., 16: 319.
- Large D.E., Abdelmessih R.G., Fink E.A., Auguste D.T. (2021). Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Adv. Drug Deliv. Rev., 176: 113851.
- Lascelles B.D.X., Rausch-Derra L.C., Wofford J.A., Huebner M. (2016). Pilot, randomized, placebo-controlled clinical field study to evaluate the effectiveness of bupivacaine liposome injectable suspension for the provision of post-surgical analgesia in dogs undergoing stifle surgery. BMC Vet. Res., 12.
- Le N.T.T., Cao V. Du, Nguyen T.N.Q., Le T.T.H., Tran T.T., Hoang Thi T.T. (2019). Soy lecithin-derived liposomal delivery systems: surface modification and current applications. Intl. J. Mol. Sci., 20: 4706.
- Levine D.G., Epstein K.L., Neelis D.A., Ross M.W. (2009). Effect of topical application of 1% diclofenac sodium liposomal cream on inflammation in healthy horses undergoing intravenous regional limb perfusion with amikacin sulfate. Am. J. Vet. Res., 70: 1323–1325.
- Li M., Du C., Guo N., Teng Y., Meng X., Sun H., Li S., Yu P., Galons H. (2019). Composition design and medical application of liposomes. Eur. J. Med. Chem., 164: 640–653.
- Lin T., Rodriguez C.O., Li Y. (2015). Nanomedicine in veterinary oncology. Vet. J., 205: 189–197.
- Liu P., Chen G., Zhang J. (2022). A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives. Molecules, 27.
- Liu Y., Castro Bravo K.M., Liu J. (2021). Targeted liposomal drug delivery: a nanoscience and biophysical perspective. Nanoscale Horiz., 6: 78–94.
- Lopez M., Schachner E. (2015). Diagnosis, prevention, and management of canine hip dysplasia: a review. Vet. Med. (Auckland, N.Z.), 6: 181.
- Lúcia A., Valente L., Paulo P., Vieira De Sá M., Alcântara De Santana W. (2020). The importance of pharmaceutical care in veterinary medicine. Intl. J. Inform. Res. Rev., 7: 6809–6814.
- Luo W., Chen D., Wu M., Li Z., Tao Y., Liu Q., Pan Y., Qu W., Yuan Z., Xie S. (2019). Pharmacokinetics/Pharmacodynamics models of veterinary antimicrobial agents. J. Vet. Sci., 20.
- Madni A., Sarfraz M., Rehman M., Ahmad M., Akhtar N., Ahmad S., Tahir N., Ijaz S., Al-Kassas R., Löbenberg R. (2014). Liposomal drug delivery: a versatile platform for challenging clinical applications. J. Pharm. Pharm. Sci., 17: 401.
- Mahendra Kumar S., Rajni Y., Sandeep Prasad T. (2023). Recent advances in nanotechnology. Intl. J. Nanomater., Nanotechnol. Nanomed., 9: 015–023.
- Martin M.S., Kleinhenz M.D., Viscardi A. V., Curtis A.K., Johnson B.T., Montgomery S.R., Lou M.E., Coetzee J.F. (2022). Effect of bupivacaine liposome suspension administered as a cornual nerve block on indicators of pain and distress during and after cautery dehorning in dairy calves. J. Dairy Sci., 105: 1603–1617.
- Mathiyazhakan M., Wiraja C., Xu C. (2018). A concise review of gold nanoparticles-based photo-responsive liposomes for controlled drug delivery. Nano-Micro Lett., 10: 10.
- Meena N.S., Sahni Y.P., Singh R.P. (2018). Applications of nano-technology in veterinary therapeutics. J. Entomol. Zool. Stud., 6: 167–175.
- Meeusen E.N.T., Walker J., Peters A., Pastoret P.P., Jungersen G. (2007). Current status of veterinary vaccines. Clin. Microbiol. Rev., 20: 489.
- Meier V.S., Beatrice L., Turek M., Poirier V.J., Cancedda S., Stiborova K., Körner M., Marconato L., Weyland M.S., Rohrer Bley C. (2019). Outcome and failure patterns of localized sinonasal lymphoma in cats treated with first-line single-modality radiation therapy: a retrospective study. Vet. Comparative Oncol., 17: 528–536.
- Moghimipour E., Rezaei M., Ramezani Z., Kouchak M., Amini M., Angali K.A., Dorkoosh F.A., Handali S. (2018). Folic acid-modified liposomal drug delivery strategy for tumor targeting of 5-fluorouracil. Eur. J. Pharm. Sci., 114: 166–174.
- Mohamed M., Abu Lila A.S., Shimizu T., Alaaeldin E., Hussein A., Sarhan H.A., Szebeni J., Ishida T. (2019). PEGylated liposomes: immunological responses. Sci. Technol. Adv. Mater., 20: 710.
- Muller C., Gines J.A., Conzemius M., Meyers R., Lascelles B.D.X. (2018). Evaluation of the effect of signalment and owner-reported impairment level on accelerometer-measured changes in activity in osteoarthritic dogs receiving a non-steroidal anti-inflammatory. Vet. J. (London, England : 1997), 242: 48–52.
- Nsairat H., Khater D., Sayed U., Odeh F., Al Bawab A., Alshaer W. (2022). Liposomes: structure, composition, types, and clinical applications. Heliyon, 8.
- Okechukwu D.C., Nnamani P.O., Attama A.A., Onugwu A.L., Okore V.C., Onuigbo E.B. (2023). Thermostability and immunostimula-tory activity of cationic liposome-based Newcastle disease virus vaccine. Sci. View J., 4: 308–317.
- Olusanya T.O.B., Ahmad R.R.H., Ibegbu D.M., Smith J.R., Elkordy A.A. (2018). Liposomal drug delivery systems and anticancer drugs. Molecules, 23.
- Pasarin D., Ghizdareanu A.-I., Enascuta C.E., Matei C.B., Bilbie C., Paraschiv-Palada L., Veres P.-A. (2023). Coating materials to increase the stability of liposomes. Polymers, 15.
- Paul S., Majumdar S., Chakraborty M. (2023). Revolutionizing ocular drug delivery: recent advancements in in situ gel technology. Bull Natl. Res. Centre., 47: 1–16.
- Petros R.A., DeSimone J.M. (2010). Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Dis., 9: 615–627.
- Pham S.H., Choi Y., Choi J. (2020). Stimuli-responsive nanomaterials for application in antitumor therapy and drug delivery. Pharmaceutics, 12: 630.
- Reader R.C., McCarthy R.J., Schultz K.L., Volturo A.R., Barton B.A., O’Hara M.J., Abelson A.L. (2020). Comparison of liposomal bupivacaine and 0.5% bupivacaine hydrochloride for control of postoperative pain in dogs undergoing tibial plateau leveling osteotomy. J. Am. Vet. Med. Assoc., 256: 1011–1019.
- Riaz M., Riaz M., Zhang X., Lin C., Wong K., Chen X., Zhang G., Lu A., Yang Z. (2018). Surface functionalization and targeting strategies of liposomes in solid tumor therapy: a review. Intl. J. Mol. Sci., 19: 195.
- Riley L.M., Satchell L., Stilwell L.M., Lenton N.S. (2021). Effect of massage therapy on pain and quality of life in dogs: a cross sectional study. Vet. Rec., 189.
- Robson A.-L., Dastoor P.C., Flynn J., Palmer W., Martin A., Smith D.W., Woldu A., Hua S. (2018). Advantages and limitations of current imaging techniques for characterizing liposome morphology. Front. Pharmacol., 9.
- Ross K., Senapati S., Alley J., Darling R., Goodman J., Jeffer- son M., Uz M., Guo B., Yoon K.-J., Verhoeven D., Kohut M., Mallapragada S., Wannemuehler M., Narasimhan B. (2019). Single dose combination nanovaccine provides protection against influenza A virus in young and aged mice. Biomater. Sci., 7: 809–821.
- Rukavina Z., Vanić Ž. (2016). Current trends in development of liposomes for targeting bacterial biofilms. Pharmaceutics, 8.
- Sadozai H., Saeidi D. (2013). Recent developments in liposome-based veterinary therapeutics. ISRN Vet. Sci., 2013: 1–8.
- Sainaga Jyothi V.G.S., Bulusu R., Venkata Krishna Rao B., Pranothi M., Banda S., Kumar Bolla P., Kommineni N. (2022). Stability characterization for pharmaceutical liposome product development with focus on regulatory considerations: an update. Intl. J. Pharm., 624: 122022.
- Sapino S., Chindamo G., Chirio D., Morel S., Peira E., Vercelli C., Gallarate M. (2022). Nanocarriers in veterinary medicine: a challenge for improving osteosarcoma conventional treatments. Nano-materials, 12: 4501.
- Saraswat A.L., Maher T.J. (2020). Development and optimization of stealth liposomal system for enhanced in vitro cytotoxic effect of quercetin. J. Drug Deliv. Sci. Technol., 55: 101477.
- Saravanakumar K., Hu X., Ali D.M., Wang M.-H. (2019). Emerging strategies in stimuli-responsive nanocarriers as the drug delivery system for enhanced cancer therapy. Curr. Pharm. Design., 25: 2609–2625.
- Saravanan P., Sreenivasa B.P., Selvan R.P.T., Basagoudanavar S.H., Hosamani M., Reddy N.D., Nathanielsz J., Derozier C., Venkataramanan R. (2015). Protective immune response to liposome adjuvanted high potency foot-and-mouth disease vaccine in Indian cattle. Vaccine, 33: 670–677.
- Schwendener R.A. (2014). Liposomes as vaccine delivery systems: A review of the recent advances. Ther. Adv. Vaccines, 2: 159–182.
- Scott K.A., Qureshi M.H., Cox P.B., Marshall C.M., Bellaire B.C., Wilcox M., Stuart B.A.R., Njardarson J.T. (2020). A structural analysis of the FDA green book-approved veterinary drugs and roles in human medicine. J. Med. Chem., 63: 15449–15482.
- Selim A., Lila A., Ishida T. (2017). Liposomal delivery systems: design optimization and current applications. Biol. Pharm. Bull., 40: 1–10.
- Sepúlveda C.T., Alemán A., Zapata J.E., Montero M.P., Gómez-Guillén M.C. (2021). Characterization and storage stability of spray dried soy-rapeseed lecithin/trehalose liposomes loaded with a tilapia viscera hydrolysate. Innov. Food Sci. Emerg. Technol., 71: 102708.
- Sercombe L., Veerati T., Moheimani F., Wu S.Y., Sood A.K., Hua S. (2015). Advances and challenges of liposome assisted drug delivery. Front. Pharmacol., 6.
- Shilo-Benjamini Y., Cern A., Zilbersheid D., Hod A., Lavy E., Barasch D., Barenholz Y. (2022). A case report of subcutaneously injected liposomal cannabidiol formulation used as a compassion therapy for pain management in a dog. Front. Vet. Sci., 9.
- Sogut O., Aydemir Sezer U., Sezer S. (2021). Liposomal delivery systems for herbal extracts. J. Drug Deliv. Sci. Technol., 61.
- Soliman W.S., Shaapan R.M., Mohamed L.A., Gayed S.S.R. (2019). Recent biocontrol measures for fish bacterial diseases, in particular to probiotics, bio-encapsulated vaccines, and phage therapy. Open Vet. J., 9: 190.
- Sriwidodo, Umar A.K., Wathoni N., Zothantluanga J.H., Das S., Luck-anagul J.A. (2022). Liposome-polymer complex for drug delivery system and vaccine stabilization. Heliyon, 8.
- Subhan M.A., Yalamarty S.S.K., Filipczak N., Parveen F., Torchilin V.P. (2021). Recent advances in tumor targeting via EPR effect for cancer treatment. J. Pers. Med., 11.
- Subramanian P., Kurek M.A., Jensen I.-J. (2021). Lipid-based nano-carrier system for the effective delivery of nutraceuticals. Molecules, 26: 5510.
- Tatli Seven P., Seven I., Gul Baykalir B., Iflazoglu Mutlu S., Salem A.Z.M. (2018). Nanotechnology and nano-propolis in animal production and health: an overview. Italian J. Animal Sci., 17: 921–930.
- Tinkle S., McNeil S.E., Mühlebach S., Bawa R., Borchard G., Barenholz Y. (Chezy), Tamarkin L., Desai N. (2014). Nanomedicines: addressing the scientific and regulatory gap. Ann. N. Y. Acad. Sci., 1313: 35–56.
- Torrente C., Vigueras I., Manzanilla E.G., Villaverde C., Fresno L., Carvajal B., Fiñana M., Costa-Farré C. (2017). Prevalence of and risk factors for intraoperative gastroesophageal reflux and postanesthetic vomiting and diarrhea in dogs undergoing general anesthesia. J. Vet. Emerg. Critical Care, 27: 397–408.
- Tseu G.Y.W., Kamaruzaman K.A. (2023). A review of different types of liposomes and their advancements as a form of gene therapy treatment for breast cancer. Molecules, 28.
- Turner H., Séguin B., Worley D.R., Ehrhart N.P., Lafferty M.H., Withrow S.J., Selmic L.E. (2017). Prognosis for dogs with stage III osteosarcoma following treatment with amputation and chemo-therapy with and without metastasectomy. J. Am. Vet. Med. Assoc., 251: 1293–1305.
- Uhl P., Bajraktari-Sylejmani G., Witzigmann D., Bay C., Zimmermann S., Burhenne J., Weiss J., Haefeli W.E., Sauter M. (2023). A nanocarrier approach for oral peptide delivery: evaluation of cell-penetrating-peptide-modified liposomal formulations in dogs. Adv. Therap., 6.
- van der Koog L., Gandek T.B., Nagelkerke A. (2022). Liposomes and extracellular vesicles as drug delivery systems: a comparison of composition, pharmacokinetics, and functionalization. Adv. Healthcare Mater., 11.
- van der Meel R., Vehmeijer L.J.C., Kok R.J., Storm G., van Gaal E.V.B. (2013). Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status. Adv. Drug Deliv. Rev., 65: 1284–1298.
- Ventola C.L. (2017). Progress in nanomedicine: approved and investigational nanodrugs. P & T Peer-rev. J. Formulary Manag., 42: 742–755.
- Verma J., Warsame C., Seenivasagam R.K., Katiyar N.K., Aleem E., Goel S. (2023). Nanoparticle-mediated cancer cell therapy: basic science to clinical applications. Cancer Metastasis Rev., 42: 601–627.
- Wahab M.S., Hair-Bejo M., Omar A.R., Ideris A. (2017). Hatchery vaccination using liposomes as vaccine delivery against infectious bursal disease in broiler chickens. J. Animal Vet. Adv., 16: 122–128.
- Wang Y., Grainger D.W. (2022). Regulatory considerations specific to liposome drug development as complex drug products. Front. Drug Deliv., 2.
- Withers S.S., York D., Johnson E., Al-Nadaf S., Skorupski K.A., Rodriguez C.O., Burton J.H., Guerrero T., Sein K., Wittenburg L., Rebhun R.B. (2018). In vitro and in vivo activity of liposome-encapsulated curcumin for naturally occurring canine cancers. Vet. Comp. Oncol., 16: 571–579.
- Yan W., Leung S.S., To K.K. (2020). Updates on the use of liposomes for active tumor targeting in cancer therapy. Nanomedicine, 15: 303–318.
- Yao Y., Zhou Y., Liu L., Xu Y., Chen Q., Wang Y., Wu S., Deng Y., Zhang J., Shao A. (2020). Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Front. Mol. Biosci., 7.
- Youssef F.S., El-Banna H.A., Elzorba H.Y., Galal A.M. (2019). Application of some nanoparticles in the field of veterinary medicine. Intl. J. Vet. Sci. Med., 7: 78–93.
- Zabielska-Koczywąs K., Lechowski R. (2017). The use of liposomes and nanoparticles as drug delivery systems to improve cancer treatment in dogs and cats. Molecules, 22: 2167.
- Zabielska-Koczywąs K., Wojtalewicz A., Lechowski R. (2017). Current knowledge on feline injection-site sarcoma treatment. Acta Vet. Scand., 59: 47.
- Zaheer T., Pal K., Zaheer I. (2021). Topical review on nano-vaccinology: biochemical promises and key challenges. Process Biochem., 100: 237–244.
- Zhu M., Wang R., Nie G. (2014). Applications of nanomaterials as vaccine adjuvants. Hum. Vaccines Immunother., 10: 2761–2774.